Annals of Clinical and Translational Neurology

Article	Citations
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia	130
The case of a 49‐year‐old man with involuntary toe movements	95
Issue Information	81
The Case of a 25‐Year‐Old Woman With Isolated Head Tremor	57
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	53
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	52
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	51
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	50
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	49
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	48
SNUPN ‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights	48
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	47
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	46
Association of serum Spp1 levels with disease progression in ALS and SBMA	45
Discrepant expressive language lateralization in children and adolescents with epilepsy	45
Order from chaos: Using CSF proteomics to predict ALS progression	44
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /D	43
Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis	43
SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis	42
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	42
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐ AChR Antibody‐	42
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	41
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	39
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	39
Dementia Incidence in Individuals With Parkinson's Disease in the Framingham Heart Study	37

Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	37
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	36
Cognitive impairment in pulmonary arterial hypertension	36
Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease	36
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	35
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab	34
Peripheral nervous system manifestations of MOG antibody associated disease	33
Development of a Prediction Model for Progression Risk in High‐Grade Gliomas Based on Habitat Radiomics and Pathomics	33
Issue Information	32
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	32
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability	32
Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study	32
The Case of a 28‐Year‐Old Woman With Medically Refractory Focal Epilepsy	31
Efficacy of Intermittent Theta‐Burst Stimulation for Prolonged Disorders of Consciousness: A Prospective, Randomized, Controlled Trial	31
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)	31
Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study	29
The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment	29
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention	29
Cerebellar impulsivity–compulsivity assessment scale	29
Correlation of slow‐wave sleep with motor and nonmotor progression in Parkinson's disease	28
Expanding Hereditary Spastic Paraplegias Limits: Biallelic SPAST Variants in Cerebral Palsy Mimics	28
Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease	28
Intracranial plaque with large lipid core is associated with embolic stroke of undetermined source	28
Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review	28
Corrigendum: Genome sequencing in persistently unsolved white matter disorders	28
Visceral and emotional responses to direct electrical stimulations of the cortex	27
Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy	27
Dose–exposure–efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy	27
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons	27
Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC	27
Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers	27
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis	27
Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis	26
Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study	26
Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study	26
Prolonged venous transit is associated with worse neurological recovery in successfully reperfused large vessel strokes	26
A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression	26
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience	25
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy	25
Cortical networks of parkinsonian gait: a metabolic and functional connectivity study	25
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone	25
Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study	25
Predictors of mTICI 2c/3 over 2b in patients successfully recanalized with mechanical thrombectomy	25
Exosomal circ‐AHCY promotes glioblastoma cell growth via Wnt/β‐catenin signaling pathway	25
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease	25
Issue Information	24
Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria	24
Issue Information	24
Laser interstitial thermal therapy in the management of bottom‐of‐sulcus dysplasia‐related epilepsy	24
Horizontal gaze palsy with progressive scoliosis: Further expanding the ROBO3 spectrum	23

Characteristics of Cerebral Palsy in the Midwestern US	23
Effectiveness of rTMS on Working Memory and Inhibitory Impairments in Patients With Post‐Stroke Executive Deficits	23
RETRACTION: α‐Synuclein Conformational Antibodies Fused to Penetratin are Effective in Models of Lewy Body Disease	23
Progressive Myoclonus Epilepsy: Distinctive MRI Changes in Cerebellar and Motor Networks	22
Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning	22
Ketogenic Diet as an Epigenetic Therapy in SETD1B ‐Related Epilepsy	22
Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting	22
Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2‐allelic disorders	22
The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis	22
Transcranial pulse stimulation in the treatment of mild neurocognitive disorders	22
Problematic Internet Use in Frontotemporal Dementia: A Case Series	22
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling	22
Intracerebral Hemorrhage Induces Monocyte TNF Signaling in Patients That Is Suppressed by BAF 312	21
COVID‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis	21
Retina as a potential biomarker for the early stage of Alzheimer's disease spectrum	20
CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity	20
Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis	20
Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics	20
Issue Information	20
Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males	20
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy	20
A novel autosomal dominant ERLIN2 variant activates endoplasmic reticulum stress in a Chinese HSP family	19
Memory and Resting‐State Connectivity in Acute Transient Global Amnesia: A Case–Control fMRI Study	19
Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis	19
Voxel‐based dysconnectomic brain morphometry with computed tomography in Down syndrome	19
Quantity and Volume of Perivascular Spaces Are Inversely Associated With Multiple Sclerosis Relative to Cerebrovascular Disease and Migraine	19
Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy	19
The Case of a 37‐Year‐Old Woman Presenting With Subacute Weakness and Paresthesias	19
Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features	19
Circulating Interleukin‐6 Levels and Timing of Acute Ischemic Stroke Onset	19
Cerebello‐Prefrontal Connectivity Underlying Cognitive Dysfunction in Spinocerebellar Ataxia Type 2	19
The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials	19
Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis	18
Epilepsy‐Associated Variants of a Single SCN1A Codon Exhibit Divergent Functional Properties	18
Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study	18
Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia	18
Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage	17
Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH	17
A machine learning approach to predict quality of life changes in patients with Parkinson's Disease	17
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy	17
Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome	17
A PANoptosis‐Based Signature for Survival and Immune Predication in Glioblastoma Multiforme	17
Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion	16
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease	16
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing	16
Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”	16
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial	16
Modifiable factors associated with Huntington's disease progression in presymptomatic participants	16
Altered Dynamic Functional Network Connectivity in Post‐Stroke Aphasia	16
Issue Information	16
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use	16
Baseline Neuroinflammation Stratifies TSPO ‐ PET Response to Disease‐Modifying Therapy in Multiple	16
Comparison of plasma and CSF biomarkers in predicting cognitive decline	16
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis	16
	16
Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease	15
Mitochondrial dysfunction in brain tissues and Extracellular Vesicles Fragile X‐associated tremor/ataxia syndrome	15
Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy	15
Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy	15
	15
Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis	15
Non‐neurological factors associated with serum neurofilament levels in the United States population	15
Onasemnogene Abeparvovec in Patients With SMA : Interim Results of the RESTORE Registry in Japan	15
Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice	15
Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China	15
Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis	15
A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt‐ND variants	15
RETRACTION : Mechanism of ARPP21 antagonistic intron	15
Persistent Leukoencephalopathy Following H 1 N 1 Infection Associated With a Novel	14
Longitudinal serum neurofilament light kinetics in post‐anoxic encephalopathy	14
Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial	14
Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting	14
Infliximab in neurosarcoidosis: a systematic review and meta‐analysis	14
	14
Bi‐ and Mono‐Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy	14
Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event	14
NR4A1 Exerts Pro‐Tumor Role in Glioblastoma via Inducing xCT / GPX4	14
Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a “real‐world” setting	14
Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities	14
CIDP/autoimmune nodopathies with nephropathy: a case series study	14

Lesion Location and Functional Connections Reveal Cognitive Impairment Networks in Multiple Sclerosis	14
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis	14
Remyelination varies between and within lesions in multiple sclerosis following bexarotene	14
Brainstem and Cerebellar Volume Loss and Associated Clinical Features in Progressive Supranuclear Palsy	14
LRRK2 and Parkinson's disease: from genetics to targeted therapy	14
Innovative technology‐based interventions in Parkinson's disease: A systematic review and meta‐analysis	14
Argatroban plus alteplase in posterior versus anterior circulation stroke	13
Long‐term safety and efficacy of stenting on correcting internal jugular vein and cerebral venous sinus stenosis	13
Dorsolateral Cervical Cord T2 Hyperintensity in KIF1C	13
Evaluation of the Efficacy and Safety of Satralizumab in a Pregnant NMOSD Patient With AQP4 /	13
Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study	13
Patient Selection in Deep Brain Stimulation: A Role for Transcranial Direct Current Stimulation to Enhance the Levodopa Challenge?	13
Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study	13
Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset	13
The Road Not Taken: Misclassifying an Anti‐Seizure Medication as a Failure	13
A machine‐learning approach for predicting impaired consciousness in absence epilepsy	13
Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy	13
Chitotriosidase is a biomarker for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia	13
Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care	13
Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy	13
Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy	13
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants	13
Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis	13
Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis	13
Exploring if Longitudinal Changes on PET Imaging Can Serve as a Biomarker for Stiff Person Syndrome Spectrum Disorders	13
Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins	13
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI‐1601) in Friedreich's ataxia	13
Pupillary dynamics predict long‐term outcome in a cohort of acute traumatic brain injury coma patients	13
Longitudinal Assessment of Biomarkers in ALS : Discriminative Biomarkers for Disease Progression and Survival	13
Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL	12
A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's	12
Refractory Status Epilepticus Treated With Bilateral Pulvinar Deep Brain Stimulation—A Case Study	12
Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease	12
Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL	12
Prognostic Implications of Sleep Architecture for Patients Admitted to the Intensive Care Unit With Status Epilepticus	12
Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy	12
Life‐Threatening Bradycardia in Anti‐ NMDA ‐Receptor Encephalitis and a Novel Use for Permanent Pacing	12
Remarkable Recovery After Delayed High‐Dose Methylprednisolone in a Rare Case of Penetrating Spinal Cord Injury	12
Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective	12
WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy	12
The Impact of Tilburg Frailty on Poststroke Fatigue in First‐Ever Stroke Patients: A Cross‐Sectional Study With Unified Measurement Tools and Improved Statistics	12
Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder	12
4‐Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders	12
“Brain age” predicts disability accumulation in multiple sclerosis	12
Bilateral versus Unilateral Training With Rhythmic Auditory Cueing in Stroke Rehabilitation: Effects on Upper Limb Function and Interhemispheric Inhibition	12
Correction to “Efgartigimod for Generalized Myasthenia Gravis: A Multicenter Real‐World Cohort Study in China”	12
Heart meets brain: A 25‐year‐old with a constellation of neurologic symptoms and heart failure	12
Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies	12
Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia	12
After early m TICI 2b, stop or continue? Insights from the PERSIST Registry	12
Neurological diagnoses in hospitalized COVID‐19 patients during the B.1.1.529 surge	11
Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank	11
Sensitivity and specificity of the Salzburg EEG criteria for nonconvulsive status epilepticus	11
Psoriasis and dementia: A population‐based matched cohort study of adults in England	11
Association of the time of day of EVT with clinical outcomes and benefit from successful recanalization after stroke	11
Erratum to “Inferring Disease Course From Differential Exon Usage in the Wide Titinopathy Spectrum”	11
Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3 m P	11
Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures	11
Long COVID in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross‐Sectional Study	11
Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis	11
Issue Information	11
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers	11
T1−/T2‐weighted ratio reveals no alterations to gray matter myelination in temporal lobe epilepsy	11
Optimized microburst VNS elicits fMRI responses beyond thalamic‐specific response from standard VNS	11
Portable Low‐Field Magnetic Resonance Imaging in People With Human Immunodeficiency Virus	11
Baseline systolic blood pressure, hypertension history, and efficacy of remote ischemic conditioning	11
White Matter Hyperintensity Burden and Short‐Interval Change Associated With Sleep Apnoea in the UK Biobank	11
Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis	11
Women's reproductive traits and ischemic stroke: a two‐sample Mendelian randomization study	11
Meningovascular Inflammation in Cerebral Amyloid Angiopathy‐Related Cortical Superficial Siderosis	11
Novel Phenotypes and Deep Intronic Variant Expand TH‐Associated Dopa‐Responsive Dystonia Spectrum	11
CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM	11
Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report	11
Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study	11
Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder	11
Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets	11
Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue	11
SCAR32 : Functional characterization and expansion of the clinical‐genetic spectrum	11
	11
Chronological and Spatial Distribution of Skeletal Muscle Fat Replacement in FHL1‐Related Myopathies	11
Super‐Refractory Status Epilepticus ( SRSE ) in a Patient With Compound Heterozygous	11
MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children	11
The Case of a 55‐Year‐Old Man With Leg Weakness	11
B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy	11
B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity	11
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population	11
Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathw	11
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4 ‐ IgG ‐Positive	11
Using chronic recordings from a closed‐loop neurostimulation system to capture seizures across multiple thalamic nuclei	10
Observational Study of Tocilizumab in Children With Febrile Infection‐Related Epilepsy Syndrome	10
Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers	10
Precision‐Optimised Post‐Stroke Prognoses	10
Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody	10
Axonal injury, sleep disturbances, and memory following traumatic brain injury	10
Issue Information	10